NAKAMURA TUMOR ZONE PERIPHERAL VS CENTRAL UP |
285 |
181 |
All SZGR 2.0 genes in this pathway |
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA UP |
205 |
140 |
All SZGR 2.0 genes in this pathway |
CHARAFE BREAST CANCER LUMINAL VS BASAL DN |
455 |
304 |
All SZGR 2.0 genes in this pathway |
NEWMAN ERCC6 TARGETS DN |
39 |
24 |
All SZGR 2.0 genes in this pathway |
SENESE HDAC1 AND HDAC2 TARGETS DN |
232 |
139 |
All SZGR 2.0 genes in this pathway |
KINSEY TARGETS OF EWSR1 FLII FUSION DN |
329 |
219 |
All SZGR 2.0 genes in this pathway |
WAMUNYOKOLI OVARIAN CANCER LMP DN |
199 |
124 |
All SZGR 2.0 genes in this pathway |
DODD NASOPHARYNGEAL CARCINOMA UP |
1821 |
933 |
All SZGR 2.0 genes in this pathway |
RODRIGUES THYROID CARCINOMA POORLY DIFFERENTIATED DN |
805 |
505 |
All SZGR 2.0 genes in this pathway |
LANDIS BREAST CANCER PROGRESSION DN |
70 |
43 |
All SZGR 2.0 genes in this pathway |
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN |
51 |
35 |
All SZGR 2.0 genes in this pathway |
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS DN |
142 |
95 |
All SZGR 2.0 genes in this pathway |
BERENJENO TRANSFORMED BY RHOA FOREVER DN |
31 |
23 |
All SZGR 2.0 genes in this pathway |
LANDIS ERBB2 BREAST TUMORS 324 DN |
149 |
93 |
All SZGR 2.0 genes in this pathway |
BERENJENO TRANSFORMED BY RHOA DN |
394 |
258 |
All SZGR 2.0 genes in this pathway |
LINDGREN BLADDER CANCER CLUSTER 2B |
392 |
251 |
All SZGR 2.0 genes in this pathway |
TERAMOTO OPN TARGETS CLUSTER 6 |
27 |
17 |
All SZGR 2.0 genes in this pathway |
SCHAEFFER PROSTATE DEVELOPMENT 48HR DN |
428 |
306 |
All SZGR 2.0 genes in this pathway |
NING CHRONIC OBSTRUCTIVE PULMONARY DISEASE DN |
121 |
79 |
All SZGR 2.0 genes in this pathway |
LINDVALL IMMORTALIZED BY TERT DN |
80 |
56 |
All SZGR 2.0 genes in this pathway |
CUI TCF21 TARGETS 2 UP |
428 |
266 |
All SZGR 2.0 genes in this pathway |
IVANOVA HEMATOPOIESIS STEM CELL AND PROGENITOR |
681 |
420 |
All SZGR 2.0 genes in this pathway |
CREIGHTON ENDOCRINE THERAPY RESISTANCE 5 |
482 |
296 |
All SZGR 2.0 genes in this pathway |
ACEVEDO METHYLATED IN LIVER CANCER DN |
940 |
425 |
All SZGR 2.0 genes in this pathway |
IZADPANAH STEM CELL ADIPOSE VS BONE DN |
108 |
68 |
All SZGR 2.0 genes in this pathway |
CADWELL ATG16L1 TARGETS UP |
93 |
56 |
All SZGR 2.0 genes in this pathway |
CHEN METABOLIC SYNDROM NETWORK |
1210 |
725 |
All SZGR 2.0 genes in this pathway |
CHIANG LIVER CANCER SUBCLASS CTNNB1 DN |
170 |
105 |
All SZGR 2.0 genes in this pathway |
KARLSSON TGFB1 TARGETS DN |
207 |
139 |
All SZGR 2.0 genes in this pathway |
国外RB1增长目标 |
243 |
155 |
All SZGR 2.0 genes in this pathway |
CHICAS RB1 TARGETS CONFLUENT |
567 |
365 |
All SZGR 2.0 genes in this pathway |
BRUINS UVC RESPONSE LATE |
1137 |
655 |
All SZGR 2.0 genes in this pathway |
MIYAGAWA TARGETS OF EWSR1 ETS FUSIONS DN |
229 |
135 |
All SZGR 2.0 genes in this pathway |
WIEDERSCHAIN TARGETS OF BMI1 AND PCGF2 |
57 |
39 |
All SZGR 2.0 genes in this pathway |
LEE BMP2 TARGETS UP |
745 |
475 |
All SZGR 2.0 genes in this pathway |
WAKABAYASHI ADIPOGENESIS PPARG RXRA BOUND 8D |
882 |
506 |
All SZGR 2.0 genes in this pathway |
WANG MLL TARGETS |
289 |
188 |
All SZGR 2.0 genes in this pathway |
KRIEG HYPOXIA NOT VIA KDM3A |
770 |
480 |
All SZGR 2.0 genes in this pathway |
ACEVEDO FGFR1 TARGETS IN PROSTATE CANCER MODEL DN |
308 |
187 |
All SZGR 2.0 genes in this pathway |
DURAND STROMA S UP |
297 |
194 |
All SZGR 2.0 genes in this pathway |
ZWANG TRANSIENTLY UP BY 1ST EGF PULSE ONLY |
1839 |
928 |
All SZGR 2.0 genes in this pathway |